pros and cons to glp 1 In my latest blog, The of GLP-1 Agonist Medications, I walk through what consider before starting, or while using, medications such as Ozempic, Wegovy, or Mounjaro. These medications 2026 Employee Benefits Trends: Should

& Fahmi, H

Clients with Type 1 Diabetes, pregnant or nursing or have/had thyroid cancer are NOT candidates for Semaglutide

The key principle is that any combination therapy should be initiated and monitored under close medical supervision, with dose adjustments made based on glucose monitoring results and individual patient response

Among those who do, one-third reported that offering coverage contributes significantly to their healthcare spend

The same authors also noted that kyphosis occurs in similar proportions in individuals with a deletion and mUPD undergoing rhGH therapy, but among untreated patients, it is more prevalent in those with a deletion rather than mUPD (p=0.001)

Ozempic Was Used by Two Million Medicare Part D Enrollees in 2024, Up from Fewer Than 150,000 in 2019 Semaglutide, the GLP-1 drug branded as Ozempic, Rybelsus, and Wegovy, was the most used GLP-1 in 2024